The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study
Open accessAbstract
Background and aim: Helicobacter pylori infection and gastric atrophy are both risk factors for gastric cancer. We aimed to elucidate the natural history of gastric cancer development according to H pylori infection and gastric atrophy status. Subjects and methods: A total of 9293 participants in a mass health appraisal programme were candidates for inclusion in the present prospective cohort study: 6983 subjects revisited the follow up programme. Subjects were classified into four groups according to serological status at initial endoscopy. Group A (n = 3324) had “normal” pepsinogen and were negative for H pylori antibody; group B (n = 2134) had “normal” pepsinogen and were positive for H pylori antibody; group C (n = 1082) had “atrophic” pepsinogen and were positive for H pylori antibody; and group D (n = 443) had “atrophic” pepsinogen and were negative for H pylori antibody. Incidence of gastric cancer was determined by annual endoscopic examination. Results: Mean duration of follow up was 4.7 years and the average number of endoscopic examinations was 5.1. The annual incidence of gastric cancer was 0.04% (95% confidence interval (CI) 0.02–0.09), 0.06% (0.03–0.13), 0.35% (0.23–0.57), and 0.60% (0.34–1.05) in groups A, B, C, and D, respectively. Hazard ratios compared with group A were 1.1 (95% CI 0.4–3.4), 6.0 (2.4–14.5), and 8.2 (3.2–21.5) in groups B, C, and D, respectively. Age, sex, and “group” significantly served as independent valuables by multivariate analysis. Conclusions: The combination of serum pepsinogen and anti- H pylori antibody provides a good predictive marker for the development of gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
Schistosomes, liver flukes and Helicobacter pylori.
(1994) · PubMed · Cited by 2,352
Helicobacter pylori Infection and Gastric Carcinoma among Japanese Americans in Hawaii
Nomura, A., Stemmermann, G. N., Chyou, P.-H., Kato, I., Perez-Perez, G. I., & Blaser, M. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251604 · Cited by 1,762
Estimates of the worldwide incidence of eighteen major cancers in 1985
Parkin, D. M., Pisani, P., & Ferlay, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540413 · Cited by 1,638
Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacey, A. R., Wald, N., & Sitas, F. (1991) · BMJ · doi:10.1136/bmj.302.6788.1302 · Cited by 1,380
An international association between Helicobacter pylori infection and gastric cancer
The EUROGAST Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)90938-d · Cited by 1,155
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
Huang, J.-Q., Sridhar, S., Chen, Y., & Hunt, R. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70422-6 · Cited by 957
Samloff, I. M., Varis, K., Ihamäki, T., Siurala, M., & Rotter, J. I. (1982) · PubMed · Cited by 515
Karnes, W. E., Samloff, I. M., Siurala, M., Kekki, M., Sipponen, P., Kim, S. W. R., & Walsh, J. H. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90474-y · Cited by 448
[Helicobacter pylori infection and development of gastric cancer].
Kamada, T., Kusunoki, H., Hata, J., et al. (2005) · PubMed · Cited by 425
Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology
Samloff, I. M., Varis, K., Ihamaki, T., Siurala, M., & Rotter, J. I. (1982) · Gastroenterology · doi:10.1016/0016-5085(82)90176-7 · Cited by 414
Helicobacter pylori Infection and the Development of Gastric Cancer
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200111000-00023 · Cited by 360
Serum pepsinogens as a screening test of extensive chronic gastritis
Miki, K., Ichinose, M., Shimizu, A., Huang, S. C., Oka, H., Furihata, C., Matsushima, T., & Takahashi, K. (1987) · Gastroenterologia Japonica · doi:10.1007/bf02774209 · Cited by 301
Virulence Factors of Helicobacter pylori Responsible for Gastric Diseases in Mongolian Gerbil
Ogura, K., Maeda, S., Nakao, M., Watanabe, T., Tada, M., Kyutoku, T., Yoshida, H., Shiratori, Y., & Omata, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1601 · Cited by 293
Self-citationThe long term results of endoscopic surveillance of premalignant gastric lesions
Whiting, J. L., Sigurdsson, A., Rowlands, D. C., Hallissey, M. T., & Fielding, J. W. L. (2002) · Gut · doi:10.1136/gut.50.3.378 · Cited by 277
(1993) · PubMed · Cited by 276
Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma
Hansson, L.-E., Engstrand, L., Nyrén, O., Evans, D. J., Lindgren, A., Bergström, R., Andersson, B., Athlin, L., Bendtsen, O., & Tracz, P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90954-b · Cited by 272
Samloff, I. M., & Liebman, W. M. (1973) · Gastroenterology · doi:10.1016/s0016-5085(19)33138-5 · Cited by 256
Cellular Localization of Group I Pepsinogens in Human Gastric Mucosa by Immunofluorescence
Samloff, I. M. (1971) · Gastroenterology · doi:10.1016/s0016-5085(19)33596-6 · Cited by 251
Accuracy of screening for gastric cancer using serum pepsinogen concentrations
Kitahara, F., Kobayashi, K., Sato, T., Kojima, Y., Araki, T., & Fujino, M. A. (1999) · Gut · doi:10.1136/gut.44.5.693 · Cited by 233
Possible role ofHelicobacter pylori infection in early gastric cancer development
Asaka, M., Kimura, T., Kato, M., Kudo, M., Miki, K., Ogoshi, K., Kato, T., Tatsuta, M., & Graham, D. Y. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2691::aid-cncr2820731107>3.0.co;2-2 · Cited by 213
Maeda, S., Yoshida, H., Ogura, K., Mitsuno, Y., Hirata, Y., Yamaji, Y., Akanuma, M., Shiratori, Y., & Omata, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.8540 · Cited by 197
Self-citationHelicobacter pylori infection and gastric cancer
Matysiak-Budnik, T., & Mégraud, F. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.020 · Cited by 190
Maeda, S., Akanuma, M., Mitsuno, Y., Hirata, Y., Ogura, K., Yoshida, H., Shiratori, Y., & Omata, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105381200 · Cited by 190
Self-citationMolecular epidemiology, pathogenesis and prevention of gastric cancer
Stadtländer, C. T. K.-H., & waterbor, J. W. (1999) · Carcinogenesis · doi:10.1093/carcin/20.12.2195 · Cited by 183
Kokkola, A., Kosunen, T. U., Puolakkainen, P. A., Sipponen, P., Härkönen, M., LAXÉN, F., Virtamo, J. R. K., Haapiainen, R. K., & Rautelin, H. (2003) · Apmis · doi:10.1034/j.1600-0463.2003.1110604.x · Cited by 155
Watanabe, Y., Kurata, J. H., Mizuno, S., et al. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018833819860 · Cited by 124
Kokkola, A., Haapiainen, R. K., LAXÉN, F., Puolakkainen, P. A., Kivilaakso, E. O., Virtamo, J. R. K., & Sipponen, P. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.12.979 · Cited by 107
Hirata, Y., Maeda, S., Mitsuno, Y., Tateishi, K., Yanai, A., Akanuma, M., Yoshida, H., Kawabe, T., Shiratori, Y., & Omata, M. (2002) · Gastroenterology · doi:10.1053/gast.2002.37044 · Cited by 78
Self-citationHelicobacter pylori infection in japanese patients with adenocarcinoma of the stomach
Blaser, M. J., Kobayashi, K., Cover, T. L., et al. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550518 · Cited by 76
Matsushima, M., Miki, K., Ichinose, M., Kakei, N., Yahagi, N., Suzuki, T., Shimizu, Y., Ishihama, S., Tsukada, S., Kurokawa, K., et al. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1871-6_17 · Cited by 56
Cited by
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Kyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
Screening for gastric cancer in Asia: current evidence and practice
Leung, W. K., Wu, M.-S., Kakugawa, Y., Kim, J. J., Yeoh, K.-G., Goh, K. L., Wu, K.-C., Wu, D.-C., Sollano, J., Kachintorn, U., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70072-x · Cited by 822
Dinis-Ribeiro, M., Areia, M., de Vries, A., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., et al. (2012) · Endoscopy · doi:10.1055/s-0031-1291491 · Cited by 680
Metadata
- Authors
- Watabe, H., Mitsushima, T., Yamaji, Y., Okamoto, M., Wada, R., Kokubo, T., Doi, H., Yoshida, H., Kawabe, T., & Omata, M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-05-11
- Volume
- 54
- Issue
- 6
- Pages
- 764-768
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2102142721
- Cited by
- 401
- References
- 34
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.